Breaking News Instant updates and real-time market news.

2022-01-20 15:11:03 PBCT People's United $19.55 / -0.795 (-3.91%) 15:11 01/20/22 01/20 15:11 01/20/22 15:11	Peoples United Financial options imply 3.1% move in share price post-earnings Pre-earnings options volume in Peoples United Financial is 3.4x normal with puts leading calls 7:3. Implied volatility suggests the market is anticipating a move near 3.1%, or 60c, after results are released. Median move over the past eight quarters is 2.5%.

2022-01-20 15:11:03

PBCT

People's United

$19.55 / -0.795 (-3.91%)

15:11

01/20/22

01/20

15:11

01/20/22

15:11

Peoples United Financial options imply 3.1% move in share price post-earnings

Pre-earnings options volume in Peoples United Financial is 3.4x normal with puts leading calls 7:3. Implied volatility suggests the market is anticipating a move near 3.1%, or 60c, after results are released. Median move over the past eight quarters is 2.5%.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	JPMorgan's Dimon: U.S. economy strong, consumer strong » 08:13 05/23/22 05/23 08:13 05/23/22 08:13 JPM JPMorgan $117.34 / -0.945 (-0.80%) Says "prepared"… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JPM JPMorgan $117.34 / -0.945 (-0.80%) 08:09 Today JPMorgan's Jamie Dimon on Investor Day: 'We should have done this earlier' 06:17 Today JPMorgan sees 12.5%-13% CET1 ratio at 1Q24 06:17 Today JPMorgan sees FY22 NII excluding Markets $56B+ vs. previous $53B+ view 05/13/22 Soros buys Lucid, exits GM in Q1 JPM JPMorgan $117.34 / -0.945 (-0.80%) 05/13/22 Jefferies JPMorgan price target lowered to $125 from $141 at Jefferies 05/03/22 Oppenheimer Oppenheimer upgrades JPMorgan to Outperform on recent share weakness 05/03/22 Oppenheimer JPMorgan upgraded to Outperform from Perform at Oppenheimer 04/14/22 Argus JPMorgan price target lowered to $155 from $177 at Argus JPM JPMorgan $117.34 / -0.945 (-0.80%) 04/13/22 JPMorgan reports Q1 EPS $2.63, consensus $2.69 04/12/22 Notable companies reporting before tomorrow's open 04/12/22 Notable companies reporting before tomorrow's open 01/14/22 JPMorgan reports Q4 EPS $3.33, consensus $3.01 JPM JPMorgan $117.34 / -0.945 (-0.80%) 05/19/22 BlackRock, JPMorgan tell Texas they're not boycotting energy firms, Reuters says 05/18/22 JPMorgan investors reject Dimon's $50M bonus, WSJ reports 05/12/22 Instacart listing could happen as soon as this year, Bloomberg reports 05/08/22 Ford to sell 8M shares of Rivian with lockup expiring, CNBC reports JPM JPMorgan $117.34 / -0.945 (-0.80%) 05/14/22 Opening Day: Fracking company ProFrac comes public in downsized IPO 05/09/22 What You Missed This Week in EVs and Clean Energy 05/03/22 What You Missed On Wall Street On Tuesday 05/03/22 What You Missed On Wall Street This Morning 00:00 Today 50th Annual Global Technology, Media & Communications Conference 07/14/22 JPMorgan - JPM 08:00 Today JPMorgan JPM JPMorgan $117.34 / -0.945 (-0.80%) 04/14/22 Notable open interest changes for April 14th 02/08/22 Early notable gainers among liquid option names on February 8th 01/14/22 Unusually active option classes on open January 14th 01/04/22 Unusually active option classes on open January 4th
Recommendations	Ideal Power price target lowered to $18 from $28 at Benchmark » 08:12 05/23/22 05/23 08:12 05/23/22 08:12 IPWR Ideal Power $10.98 / -0.42 (-3.68%) Benchmark analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Events IPWR Ideal Power $10.98 / -0.42 (-3.68%) 03/14/22 Ideal Power appoints two independent members to board of directors 03/07/22 Ideal Power completes Phase I project commitments under SBIR grant 03/01/22 Ideal Power adds leading EV manufacturer to B-Tran test program 02/24/22 Ideal Power trading resumes IPWR Ideal Power $10.98 / -0.42 (-3.68%) 08/16/21 Benchmark Ideal Power assumed with a Speculative Buy at Benchmark 06/16/22 Ideal Power Inc.
Hot Stocks	Milestone Scientific announces appointment of Casamento to board of directors » 08:12 05/23/22 05/23 08:12 05/23/22 08:12 MLSS Milestone Scientific / + Milestone Scientific… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events MLSS Milestone Scientific / + 04/14/22 Milestone Scientific, Keystone Dental Group enter strategic partnership 04/14/22 Milestone Scientific expands its dental strategy with recent agreements 04/11/22 Milestone commences sale of CompuFlo Epidural, CathCheck Verification System 03/29/22 Milestone commences sales of CompuFlo Epidural at two pain clinics MLSS Milestone Scientific / + 04/04/22 Maxim Milestone Scientific price target lowered to $4 from $6 at Maxim MLSS Milestone Scientific / + 05/17/22 Milestone Scientific reports Q1 EPS (3c) vs (1c) last year 04/01/22 Milestone Scientific reports 2021 EPS (10c) vs (12c) last year 01/10/22 Milestone Scientific sees Q4 revenue over $2.6M, consensus $2.45M 01/10/22 Milestone Scientific sees FY21 revenue $10M, consensus $9.88M MLSS Milestone Scientific / + 04/01/22 Fly Intel: Pre-market Movers 06/13/22 Milestone Scientific Inc.
Hot Stocks	Axcelis announces multiple shipments of Purion M medium current implanters » 08:12 05/23/22 05/23 08:12 05/23/22 08:12 ACLS Axcelis $56.28 / -0.81 (-1.42%) Axcelis announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ACLS Axcelis $56.28 / -0.81 (-1.42%) 04/28/22 Axcelis anounces shipment of two Purion systems to chipmakers in Asia 04/14/22 Axcelis announces multiple shipments of Purion high current implanter to Asia 03/31/22 Axcelis announces follow on shipments of Purion Power Series implanters 03/17/22 Axcelis ships multiple Purion high energy systems to manufacturers in Asia ACLS Axcelis $56.28 / -0.81 (-1.42%) 03/30/22 B. Riley Axcelis price target raised to $98 from $87 at B. Riley 02/08/22 DA Davidson Axcelis price target raised to $90 from $85 at DA Davidson 12/10/21 Needham Axcelis price target raised to $76 from $64 at Needham 12/10/21 Craig-Hallum Axcelis price target raised to $80 from $68 at Craig-Hallum ACLS Axcelis $56.28 / -0.81 (-1.42%) 02/07/22 Axcelis sees Q1 EPS 92c, consensus 87c 02/07/22 Axcelis reports Q4 EPS $1.05, consensus 84c ACLS Axcelis $56.28 / -0.81 (-1.42%) 02/07/22 Fly Intel: After-Hours Movers 05/25/22 22nd Annual Institutional Investor Conference 06/01/22 50th Annual Technology, Media & Telecom Conference
Hot Stocks	Enlivex Therapeutics appoints Pomerantz to board of directors as Vice Chairman » 08:12 05/23/22 05/23 08:12 05/23/22 08:12 ENLV Enlivex Therapeutics $3.99 / +0.01 (+0.25%) , CFRX ContraFect $3.54 / +0.125 (+3.67%) Enlivex Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ENLV CFRX ENLV Enlivex Therapeutics $3.99 / +0.01 (+0.25%) 05/09/22 Enlivex Therapeutics announces poster presentation of data on Allocetra 05/05/22 Enlivex Therapeutics announces issuance of two US patents on Allocetra 04/29/22 Enlivex Therapeutics sees cash runway into 3Q24 04/29/22 Enlivex Therapeutics to initiate Phase 1b trial of Allocetra with chemotherapy CFRX ContraFect $3.54 / +0.125 (+3.67%) 05/20/22 ContraFect announce board approved grant of inducement stock option awards 04/27/22 ContraFect announces data presentations on CF-370 12/20/21 ContraFect announces recent publication of a case study on exebacase ENLV CFRX ENLV Enlivex Therapeutics $3.99 / +0.01 (+0.25%) 05/02/22 H.C. Wainwright Enlivex Therapeutics price target lowered to $15 from $33 at H.C. Wainwright CFRX ContraFect $3.54 / +0.125 (+3.67%) 02/02/22 WBB Securities ContraFect upgraded to Buy from Speculative Buy at WBB Securities 11/16/21 Mizuho ContraFect price target lowered to $9 from $10 at Mizuho 09/09/21 SVB Leerink SVB Leerink bullish on ContraFect, initiates with an Outperform 09/09/21 SVB Leerink ContraFect initiated with an Outperform at SVB Leerink ENLV CFRX ENLV Enlivex Therapeutics $3.99 / +0.01 (+0.25%) 04/29/22 Enlivex Therapeutics reports 2021 EPS (81c) vs. (90c) last year CFRX ContraFect $3.54 / +0.125 (+3.67%) 05/16/22 ContraFect reports Q1 EPS (51c), consensus (31c) 03/24/22 ContraFect reports Q4 EPS (11c), consensus (27c)

Hot Stocks	Mobivity Holdings appoints Ben Weinberger to board of directors » 08:11 05/23/22 05/23 08:11 05/23/22 08:11 MFON Mobivity Holdings / + Mobivity Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News MFON Mobivity Holdings / + 04/26/22 California Fish Grill picks Mobivity's SmartMessage for diner communication 02/24/22 Ben's Chili Bowl selects Mobivity SmarMessage for guest connection
Recommendations	Zscaler price target lowered to $200 from $330 at RBC Capital » 08:11 05/23/22 05/23 08:11 05/23/22 08:11 ZS Zscaler $136.90 / +4.67 (+3.53%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ZS Zscaler $136.90 / +4.67 (+3.53%) 05/02/22 Zscaler appoints Castle as Chief People Officer 04/13/22 Synchronoss appoints Stanley Lowe as chief information security officer 12/22/21 Zscaler officer Rajic sells $7.9M in company shares 12/20/21 Zscaler CFO sells $4.47M in common stock ZS Zscaler $136.90 / +4.67 (+3.53%) 05/19/22 Cleveland Research Zscaler partners seemed to exceed April quarter targets, says Cleveland Research 05/18/22 Mizuho Zscaler price target lowered to $210 from $350 at Mizuho 05/18/22 Barclays Zscaler price target lowered to $147 from $257 at Barclays 05/16/22 Wells Fargo Zscaler price target lowered to $200 from $350 at Wells Fargo ZS Zscaler $136.90 / +4.67 (+3.53%) 02/24/22 Zscaler sees Q3 EPS 10c-11c, consensus 11c 02/24/22 Zscaler raises FY22 EPS view to 54c-56c from 52c-56c, consensus 52c 02/24/22 Zscaler reports Q2 EPS 13c, consensus 11c 02/24/22 Notable companies reporting after market close ZS Zscaler $136.90 / +4.67 (+3.53%) 05/21/22 Some stocks that aren't as cheap as they look, Barron's says ZS Zscaler $136.90 / +4.67 (+3.53%) 03/02/22 What You Missed On Wall Street On Wednesday 03/02/22 What You Missed On Wall Street This Morning 03/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/25/22 What You Missed On Wall Street On Friday 05/27/22 Technology 05/26/22 Zscaler - ZS ZS Zscaler $136.90 / +4.67 (+3.53%) 05/20/22 Zscaler put volume heavy and directionally bearish 04/07/22 Zscaler put volume heavy and directionally bearish 01/13/22 Zscaler put volume heavy and directionally bearish 11/30/21 Zscaler options imply 8.8% move in share price post-earnings
Hot Stocks	OneSpan announces Michael Klieman as chief product officer » 08:10 05/23/22 05/23 08:10 05/23/22 08:10 OSPN OneSpan $12.04 / +0.4 (+3.44%) OneSpan announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events OSPN OneSpan $12.04 / +0.4 (+3.44%) 03/16/22 OneSpan appoints Eric Hanson as chief marketing officer 02/08/22 OneSpan, Smart Communications partner to expand e-signature integration 12/22/21 OneSpan announces headcount reductions, sees $10M-$12M in FY22 cost savings OSPN OneSpan $12.04 / +0.4 (+3.44%) 02/23/22 DA Davidson OneSpan price target lowered to $23 from $32 at DA Davidson OSPN OneSpan $12.04 / +0.4 (+3.44%) 05/03/22 OneSpan sees FY22 revenue to meet or exceed full year 2021 revenue 05/03/22 OneSpan reports Q1 adjusted EPS (1c), consensus (5c) 02/22/22 OneSpan sees FY22 revenue meeting or exceeding FY21 revenue 02/22/22 OneSpan reports Q4 adjusted EPS (24c), consensus (8c) 06/08/22 OneSpan Inc.
Hot Stocks	CymaBay announces new results from studies on seladelpar at DDW » 08:09 05/23/22 05/23 08:09 05/23/22 08:09 CBAY CymaBay $2.11 / +0.21 (+11.05%) CymaBay Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events CBAY CymaBay $2.11 / +0.21 (+11.05%) 05/12/22 CymaBay expects cash to fund operations through 2023 05/11/22 CymaBay announces presentations at DDW 2022 04/04/22 CymaBay announces publication of results from a Phase 2 study of seladelpar CBAY CymaBay $2.11 / +0.21 (+11.05%) 05/18/22 B. Riley CymaBay price target lowered to $8 from $10 at B. Riley 05/16/22 H.C. Wainwright CymaBay price target lowered to $10 from $12 at H.C. Wainwright 04/11/22 Cantor Fitzgerald CymaBay assumed with an Overweight at Cantor Fitzgerald 11/10/21 Piper Sandler Piper Sandler says buyer of CymaBay at low valuation CBAY CymaBay $2.11 / +0.21 (+11.05%) 05/12/22 CymaBay reports Q1 EPS (32c), consensus (31c) 03/17/22 CymaBay reports Q4 EPS (34c), consensus (26c) 18 Nov 06/09/22 CymaBay Therapeutics, Inc.
Hot Stocks	Urban-Gro appoints Arie Kamp as managing director, urban-gro Europe » 08:09 05/23/22 05/23 08:09 05/23/22 08:09 UGRO Urban-Gro $6.22 / +0.075 (+1.22%) urban-gro announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events UGRO Urban-Gro $6.22 / +0.075 (+1.22%) 05/11/22 Urban Gro Inc trading resumes 05/11/22 Urban Gro Inc trading halted, volatility trading pause 05/02/22 Urban-Gro closes acquisition of Emerald Construction Management 04/22/22 Urban-Gro partners with Teens for Food Justice UGRO Urban-Gro $6.22 / +0.075 (+1.22%) 05/02/22 Craig-Hallum Craig-Hallum bullish on Urban-Gro, initiates with a Buy 05/02/22 Craig-Hallum Urban-Gro initiated with a Buy at Craig-Hallum 03/21/22 Maxim Urban-Gro initiated with a Buy at Maxim 03/21/22 Maxim Urban-Gro initiated with a Buy at Maxim UGRO Urban-Gro $6.22 / +0.075 (+1.22%) 03/29/22 Urban-Gro sees FY22 revenue greater than $110M, consensus $93.79M 03/29/22 Urban-Gro reports Q4 EPS (6c), consensus (4c) 01/05/22 Urban-Gro sees 2021 revenue $62M, one est. $64.67M. UGRO Urban-Gro $6.22 / +0.075 (+1.22%) 05/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/29/22 Fly Intel: After-Hours Movers 03/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/15/22 urban-gro, Inc.

Hot Stocks	JPMorgan's Jamie Dimon on Investor Day: 'We should have done this earlier' » 08:09 05/23/22 05/23 08:09 05/23/22 08:09 JPM JPMorgan $117.34 / -0.945 (-0.80%) Comments taken from the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JPM JPMorgan $117.34 / -0.945 (-0.80%) 06:17 Today JPMorgan sees 12.5%-13% CET1 ratio at 1Q24 06:17 Today JPMorgan sees FY22 NII excluding Markets $56B+ vs. previous $53B+ view 05/13/22 Soros buys Lucid, exits GM in Q1 05/10/22 JPMorgan launches new data plaform for the buy-side JPM JPMorgan $117.34 / -0.945 (-0.80%) 05/13/22 Jefferies JPMorgan price target lowered to $125 from $141 at Jefferies 05/03/22 Oppenheimer Oppenheimer upgrades JPMorgan to Outperform on recent share weakness 05/03/22 Oppenheimer JPMorgan upgraded to Outperform from Perform at Oppenheimer 04/14/22 Argus JPMorgan price target lowered to $155 from $177 at Argus JPM JPMorgan $117.34 / -0.945 (-0.80%) 04/13/22 JPMorgan reports Q1 EPS $2.63, consensus $2.69 04/12/22 Notable companies reporting before tomorrow's open 04/12/22 Notable companies reporting before tomorrow's open 01/14/22 JPMorgan reports Q4 EPS $3.33, consensus $3.01 JPM JPMorgan $117.34 / -0.945 (-0.80%) 05/19/22 BlackRock, JPMorgan tell Texas they're not boycotting energy firms, Reuters says 05/18/22 JPMorgan investors reject Dimon's $50M bonus, WSJ reports 05/12/22 Instacart listing could happen as soon as this year, Bloomberg reports 05/08/22 Ford to sell 8M shares of Rivian with lockup expiring, CNBC reports JPM JPMorgan $117.34 / -0.945 (-0.80%) 05/14/22 Opening Day: Fracking company ProFrac comes public in downsized IPO 05/09/22 What You Missed This Week in EVs and Clean Energy 05/03/22 What You Missed On Wall Street On Tuesday 05/03/22 What You Missed On Wall Street This Morning 00:00 Today 50th Annual Global Technology, Media & Communications Conference 07/14/22 JPMorgan - JPM 08:00 Today JPMorgan JPM JPMorgan $117.34 / -0.945 (-0.80%) 04/14/22 Notable open interest changes for April 14th 02/08/22 Early notable gainers among liquid option names on February 8th 01/14/22 Unusually active option classes on open January 14th 01/04/22 Unusually active option classes on open January 4th
Hot Stocks	Armata Pharmaceuticals doses first patient in Phase 1b/2a study of AP-SA02 » 08:09 05/23/22 05/23 08:09 05/23/22 08:09 ARMP Armata Pharmaceuticals $4.52 / +0.13 (+2.96%) Armata Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Options ARMP Armata Pharmaceuticals $4.52 / +0.13 (+2.96%) 02/22/22 Armata Pharmaceuticals: FDA clears IND application for AP-PA02 02/09/22 Armata Pharmaceuticals enters securities purchase agreement with Innoviva unit 01/05/22 Armata Pharmaceuticals provides update on pseudomonas respiratory programs ARMP Armata Pharmaceuticals $4.52 / +0.13 (+2.96%) 03/17/22 Armata Pharmaceuticals reports Q4 EPS (23c), consensus (28c) ARMP Armata Pharmaceuticals $4.52 / +0.13 (+2.96%) 01/20/22 Fifteen new option listings and one option delisting on January 20th
Recommendations	Teleflex price target lowered to $380 from $390 at RBC Capital » 08:08 05/23/22 05/23 08:08 05/23/22 08:08 TFX Teleflex $287.05 / -1.55 (-0.54%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TFX Teleflex $287.05 / -1.55 (-0.54%) 05/19/22 Teleflex announces regulatory clearance for UroLift System in China 05/18/22 Teleflex's Manta Vascular Closure Device approved by Health Canada 05/13/22 Teleflex announces full U.S. commercial launch of UroLift 2, UroLift ATC 04/11/22 Teleflex announces launch of UroLift System in Japan TFX Teleflex $287.05 / -1.55 (-0.54%) 05/09/22 BofA Teleflex initiated with a Neutral at BofA 04/29/22 Truist Teleflex price target lowered to $340 from $370 at Truist 04/12/22 Truist Truist starts six stocks in Medical Supplies and Devices, assumes eight others 04/12/22 Truist Teleflex initiated with a Hold at Truist TFX Teleflex $287.05 / -1.55 (-0.54%) 04/28/22 Teleflex still sees FY22 EPS $13.70-$14.30, consensus $13.89 04/28/22 Teleflex reports Q1 adjusted EPS $2.88, consensus $2.75 02/24/22 Teleflex sees FY22 adjusted EPS $13.70-$14.30, consensus $14.04 02/24/22 Teleflex reports Q4 adjusted EPS $3.60, consensus $3.53 TFX Teleflex $287.05 / -1.55 (-0.54%) 05/09/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/16/22 Teleflex
Hot Stocks	DZS to discuss 100G-enabled optical broadband networks at FTTH Conference » 08:07 05/23/22 05/23 08:07 05/23/22 08:07 DZSI DZS $14.53 / -0.08 (-0.55%) DZS announced that chief… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events DZSI DZS $14.53 / -0.08 (-0.55%) 05/20/22 DZS announces Convergenze to deploy XGS-PON technology 05/02/22 DZS to acquire specific core assets of Adaptive Spectrum and Signal Alignment 04/29/22 DZS CTO to present at CommsDay Summit 2022 04/26/22 DZS announces ongoing partnership with Northeast Nebraska Telephone Company DZSI DZS $14.53 / -0.08 (-0.55%) 05/04/22 B. Riley DZS price target lowered to $24 from $25 at B. Riley 02/28/22 Stifel DZS resumed with a Buy at Stifel 02/14/22 B. Riley DZS price target raised to $25 from $22 at B. Riley 06/22/21 Needham DZS initiated with a Buy at Needham DZSI DZS $14.53 / -0.08 (-0.55%) 05/02/22 DZS sees FY22 revenue $380M-$410M, consensus $395.63M 05/02/22 DZS sees Q1 revenue $85M-$100M, consensus $92.47M 05/02/22 DZS reports Q1 EPS 1c, consensus (3c) 02/10/22 DZS sees FY22 revenue $380M-$410M, consensus $373.13M 05/25/22 22nd Annual Institutional Investor Conference 06/01/22 50th Annual Technology, Media & Telecom Conference 06/02/22 DZS Inc
Hot Stocks	Teva announces new efficacy, safety data from OLE study on Austedo tablets » 08:07 05/23/22 05/23 08:07 05/23/22 08:07 TEVA Teva $8.48 / +0.18 (+2.17%) Teva Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TEVA Teva $8.48 / +0.18 (+2.17%) 05/19/22 Teva EVP of R&D sells $1.07M in common stock 05/17/22 Teva granted license by MHRA for Ongavia 05/17/22 Teva announces new findings for ProAir Digihaler inhalation powder 05/10/22 Teva publishes 2021 ESG Progess Report TEVA Teva $8.48 / +0.18 (+2.17%) 05/17/22 BofA Teva upgraded to Neutral at BofA on potential opioid deal upside 05/17/22 BofA Teva upgraded to Neutral from Underperform at BofA 05/04/22 Piper Sandler Teva downgraded to Underweight from Neutral at Piper Sandler 04/05/22 Barclays Teva upgraded to Overweight from Equal Weight at Barclays TEVA Teva $8.48 / +0.18 (+2.17%) 05/03/22 Teva backs FY22 adjusted EPS view $2.40-$2.60, consensus $2.51 05/03/22 Teva reports Q1 EPS 55c, consensus 55c 02/09/22 Teva sees FY22 EPS $2.40-$2.60, consensus $2.64 02/09/22 Teva reports Q4 EPS 77c, consensus 73c TEVA Teva $8.48 / +0.18 (+2.17%) 05/10/22 Teva, Allergan offering over $5B to settle opioid suits, Bloomberg says 05/10/22 Teva, Allergan offering over $5B to settle opioid suits, Bloomberg says 12/30/21 Jury finds Teva fueled opioid addiction in NY, Reuters reports 12/30/21 Teva held liable by jury in New York in opioid trial, Bloomberg reports TEVA Teva $8.48 / +0.18 (+2.17%) 05/10/22 What You Missed On Wall Street On Tuesday 05/04/22 What You Missed On Wall Street On Wednesday 05/04/22 What You Missed On Wall Street This Morning 04/20/22 Fly Intel: Pre-market Movers 06/30/22 PDUFA Date for TV-46000/mdc-IRM TEVA Teva $8.48 / +0.18 (+2.17%) 05/11/22 Unusually active option classes on open May 11th 05/04/22 Teva put volume heavy and directionally bearish 04/05/22 Unusually active option classes on open April 5th 04/04/22 Teva call volume above normal and directionally bullish

Hot Stocks	Liminal BioSciences doses first subject in Phase 1a trial of fezagepras » 08:07 05/23/22 05/23 08:07 05/23/22 08:07 LMNL Liminal BioSciences / + Liminal BioSciences… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research LMNL Liminal BioSciences / + 03/14/22 Liminal BioSciences provides update on lead drug candidate fezagepras 03/07/22 Liminal BioSciences receives Nasdaq deficiency notice over bid price LMNL Liminal BioSciences / + 06/24/21 Fly Intel: Top five analyst downgrades 06/24/21 H.C. Wainwright Liminal BioSciences downgraded to Neutral from Buy at H.C. Wainwright 06/02/21 Fly Intel: Top five analyst downgrades 06/01/21 Piper Sandler Liminal BioSciences downgraded to Neutral from Overweight at Piper Sandler
Hot Stocks	Inspired Entertainment receives igaming license in Pennsylvania » 08:06 05/23/22 05/23 08:06 05/23/22 08:06 INSE Inspired Entertainment $10.19 / -0.2 (-1.92%) Inspired Entertainment… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events INSE Inspired Entertainment $10.19 / -0.2 (-1.92%) 04/12/22 Inspired Entertainment awarded additional 700 VLTs in Saskatchewan 03/11/22 Inspired Entertainment expects to file Form 12b-25 with SEC 03/04/22 Inspired Entertainment launches igaming content with DraftKings in Connecticut 02/08/22 Inspired Entertainment launches igaming content with Gan Limited in Michigan INSE Inspired Entertainment $10.19 / -0.2 (-1.92%) 11/29/21 B. Riley B. Riley says focus on domestic gaming suppliers with Macau 'broken' 09/09/21 Macquarie Macquarie says own online gaming into 'major catalyst' of NFL kickoff 07/23/21 Truist Truist starts Inspired Entertainment at Buy citing 'high-growth' Virtual Sports 07/23/21 Truist Inspired Entertainment initiated with a Buy at Truist INSE Inspired Entertainment $10.19 / -0.2 (-1.92%) 05/10/22 Inspired Entertainment reports Q1 GAAP EPS 5c, consensus (9c) 03/11/22 Inspired Entertainment reports Q4 GAAP EPS (5c), consensus 5c 26 May INSE Inspired Entertainment $10.19 / -0.2 (-1.92%) 03/04/22 Bet On It: Missouri House Committee pushes forward sports betting bill 02/11/22 Bet On It: Nationwide legalization efforts lead to record wagers for Super Bowl 05/25/22 22nd Annual Institutional Investor Conference 06/01/22 Inspired Entertainment 06/02/22 Inspired Entertainment 06/03/22 Inspired Entertainment
Hot Stocks	Bowlero announces agreement to acquire three bowling centers in Kansas » 08:05 05/23/22 05/23 08:05 05/23/22 08:05 BOWL Bowlero $9.49 / -0.225 (-2.32%) Bowlero announced today… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options BOWL Bowlero $9.49 / -0.225 (-2.32%) 05/12/22 Bowlero rises 8.8% 04/14/22 Bowlero announces redemption of all outstanding warrants 02/11/22 Soros Fund buys Rivian, exits Coupang in Q4 02/10/22 Bowlero rises 18.1% BOWL Bowlero $9.49 / -0.225 (-2.32%) 02/16/22 Noble Capital Bowlero initiated with an Outperform at Noble Capital 10/12/21 MKM Partners MKM starts Isos Acquisition with Buy ahead of Bowlero merger 10/11/21 MKM Partners Bowlero partner Isos Acquisition initiated with a Buy at MKM Partners BOWL Bowlero $9.49 / -0.225 (-2.32%) 02/09/22 Bowlero reports Q2 adjusted EBITDA $66.8M, up 26% y/y 00:00 Today 50th Annual Global Technology, Media & Communications Conference BOWL Bowlero $9.49 / -0.225 (-2.32%) 04/27/22 Three new option listings on April 27th
Hot Stocks	Satellogic announces enhanced operations in Australia to serve the APAC region » 08:05 05/23/22 05/23 08:05 05/23/22 08:05 SATL Satellogic $5.29 / -0.19 (-3.47%) Satellogic announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Options SATL Satellogic $5.29 / -0.19 (-3.47%) 05/04/22 Satellogic up 21% after announcing launch agreement with SpaceX 05/04/22 Satellogic signs new multiple launch agreement with SpaceX 04/25/22 Satellogic partners with Orbital Insight for high-resolution satellite imagery 04/04/22 Satellogic launches five additional spacecraft on SpaceX Transporter-4 mission SATL Satellogic $5.29 / -0.19 (-3.47%) 05/10/22 Piper Sandler Satellogic initiated with an Underweight at Piper Sandler SATL Satellogic $5.29 / -0.19 (-3.47%) 05/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/04/22 Fly Intel: Pre-market Movers SATL Satellogic $5.29 / -0.19 (-3.47%) 03/25/22 Three new option listings on March 25th
Hot Stocks	AbbVie's cariprazine for MDD achieves primary endpoint in Phase 3 study » 08:05 05/23/22 05/23 08:05 05/23/22 08:05 ABBV AbbVie $151.04 / -0.8 (-0.53%) , RGEDF Richter Gedeon $24.63 / + (+0.00%) AbbVie (ABBV) will… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ABBV ABBV AbbVie $151.04 / -0.8 (-0.53%) 05:26 Today AbbVie receives CHMP recommendation for upadacitinib approval 05/20/22 AbbVie submits NDA to FDA for ABBV-951 05/16/22 Berkshire Hathaway adds Citi, exits Wells Fargo in Q1 05/16/22 AbbVie, Cugene announce collaboration in autoimmune diseases ABBV RGEDF ABBV AbbVie $151.04 / -0.8 (-0.53%) 06:23 Today SVB Leerink AbbVie initiated with an Underperform at SVB Leerink 05/13/22 Piper Sandler Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler 05/06/22 Daiwa AbbVie downgraded to Neutral from Outperform at Daiwa 05/03/22 Morgan Stanley Vertex upgraded to Equal Weight at Morgan Stanley following AbbVie failure RGEDF Richter Gedeon $24.63 / + (+0.00%) ABBV ABBV AbbVie $151.04 / -0.8 (-0.53%) 04/29/22 AbbVie sees FY22 revenue $59.4B, consensus $60.22B 04/29/22 AbbVie sees Q2 adjusted EPS $3.38-$3.42, consensus $3.50 04/29/22 AbbVie cuts FY22 adjusted EPS view to $13.92-$14.12 from $14.00-$14.20 04/29/22 AbbVie reports Q1 adjusted EPS $3.16, consensus $3.14 ABBV ABBV AbbVie $151.04 / -0.8 (-0.53%) 05/10/22 Teva, Allergan offering over $5B to settle opioid suits, Bloomberg says 05/10/22 Teva, Allergan offering over $5B to settle opioid suits, Bloomberg says 03/07/22 Johnson & Johnson negotiating deals with two Chinese companies, FT reports ABBV ABBV AbbVie $151.04 / -0.8 (-0.53%) 05/10/22 What You Missed On Wall Street On Tuesday 05/03/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/02/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/29/22 What You Missed On Wall Street On Friday 06/02/22 38th Annual Strategic Decisions Conference 06/03/22 2022 ASCO Annual Meeting 09/07/22 2022 Wells Fargo Healthcare Conference ABBV ABBV AbbVie $151.04 / -0.8 (-0.53%) 04/29/22 Unusually active option classes on open April 29th 02/24/22 AbbVie put volume heavy and directionally bearish 01/24/22 AbbVie put volume heavy and directionally bearish 12/06/21 Unusually active option classes on open December 6th

Initiation	Tabcorp initiated with a Hold at Jefferies » 08:04 05/23/22 05/23 08:04 05/23/22 08:04 TACBY Tabcorp $7.42 / + (+0.00%) Jefferies analyst Simon… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TACBY Tabcorp $7.42 / + (+0.00%) 07/19/21 Goldman Sachs Tabcorp reinstated with a Buy at Goldman Sachs 07/06/21 CLSA Tabcorp downgraded to Outperform from Buy at CLSA
Hot Stocks	Hyundai Motor increases U.S. investment » 08:04 05/23/22 05/23 08:04 05/23/22 08:04 HYMTF Hyundai Motor $36.25 / +0.96 (+2.72%) Hyundai Motor Group is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly HYMTF Hyundai Motor $36.25 / +0.96 (+2.72%) 05/22/22 Hyundai Motor to invest more than $10 billion in U.S. by 2025 05/20/22 Hyundai Motor announces pact with State of Georgia to build EV facilities 05/03/22 Hyundai Motor America reports April retail sales of 61,668 units, down 20% y/y 04/17/22 Hyundai Motor issues first community-based NFT among automakers HYMTF Hyundai Motor $36.25 / +0.96 (+2.72%) 05/18/22 Northland SoundHound replacing Cerence at Hyundai, says Northland 06/22/21 Piper Sandler Electric vehicles will represent 94% of new car sales by 2040, says Piper HYMTF Hyundai Motor $36.25 / +0.96 (+2.72%) 03/16/22 Wall Street expert calls this small-cap stock the 'new leader' in lidar
Hot Stocks	Ascendis Pharma announces new commercial endocrinology leadership appointments » 08:04 05/23/22 05/23 08:04 05/23/22 08:04 ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) Ascendis Pharma announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 08:03 Today Ascendis Pharma announces results from VISEN's Phase 3 trial 03/13/22 Ascendis Pharma announces Phase 3 PaTHway trial of TransCon PTH data 01/13/22 Ascendis Pharma receives European approval for TransCon hGH 01/10/22 Ascendis provides update on Vision 3x3 roadmap, planned 2022 milestones ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 05/12/22 Cantor Fitzgerald Ascendis Pharma price target lowered to $180 from $230 at Cantor Fitzgerald 05/12/22 Oppenheimer Ascendis Pharma price target lowered to $154 from $166 at Oppenheimer 05/12/22 Wells Fargo Ascendis Pharma price target lowered to $176 from $190 at Wells Fargo 05/12/22 Credit Suisse Ascendis Pharma price target lowered to $123 from $194 at Credit Suisse ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 05/11/22 Ascendis Pharma reports Q1 EPS EUR (2.21) vs. EUR (1.17) 03/02/22 Ascendis Pharma reportsFY22 EPS (EUR 7.00 ) versus (EUR 8.28) in FY21 02 Sep ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 03/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Earnings	Star Equity reports Q1 EPS (5c) vs. (35c) last year » 08:04 05/23/22 05/23 08:04 05/23/22 08:04 STRR Star Equity / + Reports Q1 revenue $25M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Syndicate Events STRR Star Equity / + 04/04/22 KBS Builders wins $9M contract to manufacture four dormitories 04/01/22 Star Equity appoints Rick Coleman as CEO 03/23/22 Star Equity announce intent to nominate director candidates at Gyrodyne 03/02/22 Star Equity announces director nominations at Servotronics STRR Star Equity / + 03/22/22 Star Equity reports Q4 GAAP EPS (84c) vs. (11c) a year ago 20 Jan 10:00 Today Star Equity - STRR 05/31/22 Star Equity Holdings Inc
Hot Stocks	Ascendis Pharma announces results from VISEN's Phase 3 trial » 08:03 05/23/22 05/23 08:03 05/23/22 08:03 ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) Ascendis Pharma announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 03/13/22 Ascendis Pharma announces Phase 3 PaTHway trial of TransCon PTH data 01/13/22 Ascendis Pharma receives European approval for TransCon hGH 01/10/22 Ascendis provides update on Vision 3x3 roadmap, planned 2022 milestones 12/14/21 Ascendis to provide update on endocrinology rare disease development programs ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 05/12/22 Cantor Fitzgerald Ascendis Pharma price target lowered to $180 from $230 at Cantor Fitzgerald 05/12/22 Oppenheimer Ascendis Pharma price target lowered to $154 from $166 at Oppenheimer 05/12/22 Wells Fargo Ascendis Pharma price target lowered to $176 from $190 at Wells Fargo 05/12/22 Credit Suisse Ascendis Pharma price target lowered to $123 from $194 at Credit Suisse ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 05/11/22 Ascendis Pharma reports Q1 EPS EUR (2.21) vs. EUR (1.17) 03/02/22 Ascendis Pharma reportsFY22 EPS (EUR 7.00 ) versus (EUR 8.28) in FY21 02 Sep ASND Ascendis Pharma $95.48 / +4.61 (+5.07%) 03/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations

Events

Earnings calls, analyst events, roadshows and more

Today at 08:30

Chicago Fed National Activity Index: April 2022 Government Event
Today at 08:30

Chicago Fed National Activity Index--3 Month Moving Average: April 2022 Government Event
RSLS
Today at 08:30

ReShape Lifesciences - RSLS Conference Calls
AVPT
Today at 09:00

AvePoint Firm Sponsored Meetings

Virtual Meeting
GILT
Today at 09:30

Gilat Satellite - GILT Conference Calls
STRR
Today at 10:00

Star Equity - STRR Conference Calls
HLGN
Today at 10:00

Heliogen - HLGN Conference Calls
MGI
Today at 10:00

MoneyGram International Inc Firm Sponsored Meetings
VSTO
Today at 10:00

Vista Outdoor Firm Sponsored Meetings

New York Stock Exchange, New York, NY
AMPS
Today at 10:00

Altus Power Inc Firm Sponsored Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Peoples United Financial options imply 3.1% move in share price post-earnings

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access